Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05780814 · ClinicalTrials.gov registry record · NA

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

A NA study of Breast Cancer and Insomnia, sponsored by Johns Hopkins University.

Recruiting
Registry status
NA
Development phase
250
Enrollment target
4
Study locations

NCT05780814: Recruiting NA study of Breast Cancer and Insomnia, sponsored by Johns Hopkins University.

NCT05780814 is a NA study of Breast Cancer and Insomnia that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 250 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05780814, a NA study of Breast Cancer and Insomnia, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
NA
Development phase
250 participants
Enrollment target
4
Study locations

Study Summary

The investigators propose a randomized controlled clinical trial in 250 women with a history of early stage breast cancer who are overweight or obese with insomnia to test whether a brief, cognitive-behavioral intervention for insomnia (CBT-I) prior to behavioral weight loss (CBT-I+BWL) is superior to a sleep education control (EDU) condition followed by behavioral weight loss (EDU+BWL). The investigators will measure outcomes at baseline, 8 weeks (after completing CBT-I or EDU and prior to BWL), and at 3, 6, and 12 months.

Primary Outcome

Our primary endpoint is % total weight loss (TWL) at 12 months. We will measure weight in light clothes without shoes, using a digital scale (in pounds) and height to the nearest 0.1 cm using a calibrated stadiometer, according to standardized procedures.

Interventions

  • BEHAVIORAL Cognitive-Behavioral Therapy for Insomnia (CBT-I)
  • BEHAVIORAL Sleep Education Control (EDU)

Study Locations (4)

Maryland

  • Sidney Kimmel Comprehensive Cancer Center, the Avon Foundation Breast Center at Johns Hopkins - Baltimore
  • Johns Hopkins Bayview - Baltimore
  • Johns Hopkins Kimmel Cancer Center at Greenspring Station - Lutherville

District of Columbia

  • Sibley Memorial Hospital - Washington D.C.

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-02-01
Est. Completion 2028-12-31
Phase NA
Johns Hopkins University

1,448 total trials

What NCT05780814 shows while recruiting

NCT05780814 is an interventional study that assigns participants to a tested intervention. The registered 250 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (91% lower).

The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Cognitive-Behavioral Therapy for Insomnia (CBT-I) is the first listed.

NCT05780814 reports a single indexed study location in Maryland, District of Columbia.

Frequently Asked Questions

What is clinical trial NCT05780814 about?

NCT05780814 is a clinical study titled "The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer". The investigators propose a randomized controlled clinical trial in 250 women with a history of early stage breast cancer who are overweight or obese with insomnia to test whether a brief, cognitive-behavioral intervention for insomnia (CBT-I) prior to behavioral weight loss (CBT-I+BWL) is superior ...

What is the current status of trial NCT05780814?

This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-02-01. Estimated completion is 2028-12-31.

What conditions does trial NCT05780814 study?

This clinical trial studies the following conditions: Breast Cancer, Insomnia, Weight Gain.

What interventions are being tested in trial NCT05780814?

The interventions under investigation include: Cognitive-Behavioral Therapy for Insomnia (CBT-I) (BEHAVIORAL), Sleep Education Control (EDU) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05780814?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05780814 being conducted?

This trial has 4 study locations across District of Columbia, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05780814's enrollment target sits among peer trials

250 323rd of 1224 higher than 895 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00483249 · 250 participants · NA

    Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm

  • NCT00777712 · 250 participants

    Mechanisms Underlying Impaired Diabetic Wound Healing

  • NCT01451502 · 250 participants · NA

    Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units

  • NCT01771718 · 250 participants

    Pilot Study on In-vivo Non-invasive Skin Imaging Using Multiphoton Microscopy

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05780814, the US trial registry maintained by the National Library of Medicine. NCT05780814 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.